KPIs & Operating Metrics(New)
Advance Purchase Agreements (Apas)Breakdown Of AssetsCollabration Revenue By CategoryCollabration Revenue By Category AnnualCost Of SalesDeferred Revenue By SegmentDoses DeliveredEmployee StatisticsGrant Revenue By Category AnnualGrant Revenue By CategoyGross Margin %Gross ProfitIncome (Loss) Before Income Tax By RegionManufacturing Technology Center (Mtc)Operating Expense As A % Of Total Revenue %Operating Expense SegregationProduct Revenue By Geography %Product Revenue By Geography Annual %Product Sales By GeographyProduct Sales By Geography AnnualProfitabilityProfitability %Profitability AnnualProfitability Annual %Property And Equipment BreakdownProperty And Equipment By GeographyPurchase CommitmentsRemaining Performance ObligationRemaining Performance ObligationsRevenue By Major CustomersRevenue By Major Customers %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Contractual Obligations AnnualTotal Deferred Revenue
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Gross Profit: 2017-2025

Historic Gross Profit for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to $809.0 million.

  • Moderna's Gross Profit fell 39.99% to $809.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 67.97%. This contributed to the annual value of $1.8 billion for FY2024, which is 17.77% down from last year.
  • Latest data reveals that Moderna reported Gross Profit of $809.0 million as of Q3 2025, which was up 3,417.39% from $23.0 million recorded in Q2 2025.
  • Over the past 5 years, Moderna's Gross Profit peaked at $6.3 billion during Q4 2021, and registered a low of -$410.0 million during Q3 2023.
  • Moreover, its 3-year median value for Gross Profit was $71.0 million (2024), whereas its average is $428.4 million.
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 21,700.00% in 2021, then tumbled by 118.11% in 2023.
  • Quarterly analysis of 5 years shows Moderna's Gross Profit stood at $6.3 billion in 2021, then plummeted by 49.42% to $3.2 billion in 2022, then plummeted by 40.56% to $1.9 billion in 2023, then slumped by 87.94% to $227.0 million in 2024, then crashed by 39.99% to $809.0 million in 2025.
  • Its Gross Profit was $809.0 million in Q3 2025, compared to $23.0 million in Q2 2025 and $18.0 million in Q1 2025.